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Abstract 
BACKGROUND: The scientific substantiation for the selection of therapeutically significant dosage of 
phytocomplex in the dosage form for phonophoresis, control over the delivery of active substances into the body, 
and what affects this process require the study of the kinetics of phytocomplex flavonoids delivery during 
phonophoresis.  
AIM: The aim was to study the possibilities of controlling the process of transdermal delivery of phytocomplex 
active substances (flavonoids) during phonophoresis in vitro model experiments.  
METHODS: Working compositions with different concentrations of phytocomplex for phonophoresis were used. 
The content of flavonoids in the compositions was determined using the spectrophotometric method and was 
calculated equivalent to quercetin, the flavonoid prevailing in the phytocomplex. The study of the kinetics of 
flavonoids delivery from working compositions was carried out using Franz diffusion cells and Carbosyl-P 
membranes. The authors determined the main parameters of the process and established the dependence of the 
delivery rate of flavonoids on their initial concentration in the working composition. The authors studied the effect 
of dimethyl sulfoxide and the base-forming substances of the working composition on the kinetics of 
phytocomplex flavonoid delivery during phonophoresis.  
RESULTS: The authors recorded an increase in the rate of delivery of the active substances from working 
compositions containing dimethyl sulfoxide into the model medium by almost 1.5-2 times during the first ten 
minutes of the experiment (approximate duration of the phonophoresis procedure). The authors proposed 
technological techniques for improvement of the phonophoresis method for the phytocomplex. The possibilities of 
control over the process of transdermal delivery of the phytocomplex active ingredients during phonophoresis in 
vitro model experiments were shown.  
CONCLUSION: The obtained results provide information for further pharmacological studies of the nature and 
mechanism of the effect of phytocomplex flavonoids during phonophoresis in the rehabilitation of patients with 
osteoarthrosis. 
 
 
 
Introduction 
 
One of the promising trends in modern 
physiotherapy is the creation of new, more effective 
pharmaco-physiotherapeutic methods for the 
rehabilitation of patients, including the use of herbal 
drug products [1], [2], [3], [4], [5], [6]. When 
developing new methods, ensuring control over the 
delivery of active substances into the body and the 
ability to influence and control this process is crucial 
[7], [8], [9], [10], [11], [12]. Duration of 
physiotherapeutic procedures is limited; therefore, it is 
necessary to quickly and fully utilise the resources of 
the drug for its rational use and maximum therapeutic 
efficacy. 
This paper shows the possibility of regulating 
the process of transdermal delivery of active 
substances by the example of phonophoresis of 
phytocomplex in the rehabilitation of patients with 
osteoarthrosis. Previous studies have shown the need 
for improved technology and new, more effective 
phytocomplex dosage forms for phonophoresis [13], 
[14]. The study of the transdermal delivery of the 
phytocomplex active substances is also needed for 
the possible industrial production of a new drug based 
on the phytocomplex in the form of an ointment or gel 
suitable for phonophoresis. This allows for wider use 
of a new pharmaco-physiotherapeutic method. 
The proposed phytocomplex is a dry extract 
from grass and roots of marsh cinquefoil, grass or 
alfalfa, and multiple fruits, or cones, of common hop 
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(TOR 9375-021-00003938-11 “Marsh cinquefoil, 
alfalfa, and common hop dry extract (phytocomplex)”) 
[14]. It contains flavonoids, polysaccharides, 
coumestans, tannins, essential oils, phenol carboxylic 
acids, macro- and microelements, and vitamins [15]. 
The main active ingredients of the phytocomplex are 
flavonoids, which have anti-inflammatory, analgesic, 
antioxidant and other effects. This stipulates the 
possible use of the phytocomplex in medicine for 
inflammatory and degenerative diseases of the 
musculoskeletal system, including osteoarthritis. 
Currently, there are no systematic works in 
the literature devoted to the penetration of flavonoids 
from the medications through the skin during 
phonophoresis. 
The study aimed to study the possibilities of 
controlling the process of transdermal delivery of the 
active ingredients (flavonoids) of the phytocomplex 
during phonophoresis in vitro model experiments. 
 
 
Material and Methods 
 
Phytocomplex working compositions with 
concentrations of 5% (W1), 10% (W2) and 15% (W3) 
were used for phonophoresis in the study. The 
following substances were used as base-forming 
substances for the preparation of 10% working 
composition: Carbopol 974Р (Carbomer 974P, 
BufferGel) (C974P, Noveon Inc.) (W2) [16], [17]; 
ointment composition with 48.5 g of vaseline 
(FS.2.2.003.15, State Standard 3582-84), 15.0 g of 
anhydrous lanolin (TOR 9154-015-00333865-05), 1.5 
g of distilled monoglycerides (TOR 9145-357-
00336444-2005), and up to 100.0 g of purified water 
(FS.2.2.0020.15, State Standard 6709-72) (W4); 
ultrasound gel – Ecoultragel (Pirrone & Co. S.p.A., 
Italy) (W5). Analysis of the rheological characteristics 
of the working compositions was carried out using a 
Rheotest rotary viscometer (RN 4.1 modification, 
RHEOTEST Messgerate Medingen GmbH, Germany). 
Previously it was established that the main 
active ingredients of the phytocomplex are flavonoids, 
and the working compositions are resistant to 
exposure to ultrasound with an intensity of 0.1-1.0 
W/cm
2
.  
The content of flavonoids in working 
compositions was determined using the 
spectrophotometric method [15] and calculated 
equivalent to quercetin (Q 0125, Sigma), the flavonoid 
prevailing in the phytocomplex. To do this, an exact 
weight of the working composition (about 1 g) was 
placed in a flask with a capacity of 150 ml, 30 ml of 
70% ethanol was added, the flask was connected to a 
reflux condenser and heated in a boiling water bath 
for 30 minutes. Then the flask was cooled to room 
temperature, and its contents were filtered through a 
filter paper into a 100 ml volumetric flask. The 
extraction was repeated twice, with 70% ethanol for 
30 minutes. The extracts were filtered into the same 
volumetric flask, the filter was washed with 70% 
ethanol, and the filtrate was brought to the mark with a 
solution of 70% ethanol (solution A). In a volumetric 
flask with a capacity of 25 ml, 2 ml of solution A was 
added and brought to the volume of the solution to the 
mark with 70% ethanol (solution B). Studies were 
performed using a Titrtek MCC 1340 
spectrophotometer (Finland) at a wavelength of 370 
nm. The absorption spectra of the working 
compositions and quercetin were previously 
investigated. It was established that the base-forming 
substances do not shift the maximum optical density 
of quercetin, based on the intensity of which 
photometry was carried out. 
The content of flavonoids was 0.35 ± 0.01% in 
W1, 0.70 ± 0.02% in W2, 1.04 ± 0.03% in W3, 0.72 ± 
0.03% in W4, and 0.69 ± 0.02% in W5. 
The study of the kinetics of the transdermal 
delivery of flavonoids from working compositions 
during phonophoresis performed by diffusion through 
a semipermeable membrane in Franz diffusion cells (# 
4G-01-00-09-05, SES GmbH-Analysesysteme, 
Germany) in a V6-SFCS system using Carbosyl-P 
membranes (TOR 66-2-512-92). During 
phonophoresis, penetration of flavonoids through the 
skin follows the Fick's law, according to which the flux 
of the particles (I) diffusing through the plane 
perpendicular to the direction of diffusion is directly 
proportional to concentration gradient (dc/DX): 
           ,    (1) 
where D is the diffusion coefficient. 
The second Fick's law is usually used for 
analysing the majority of diffusion experiments: 
                   (2) 
From equation (2) it follows that the change in 
the concentration over time (dc/dt) at a distance x 
from the initial plane is proportional to the rate of 
changing the concentration gradient towards x at 
moment t. For the practical use, equation (2) should 
be integrated under appropriate boundary conditions 
[18], [19]. 
Sodium hydroxide solution, 0.1 n. (quercetin 
is very poorly soluble in water) And 0.9% sodium 
chloride solution (physiological solution) were used as 
model media. Phonophoresis was carried out using 
the labile contact technique in a continuous mode with 
ultrasound intensity of 0.6 W/cm
2
 using the UZT-1.07F 
device (Maloyaroslavets instrument factory, Russia). 
Samples were taken at certain time intervals with a 
complete replacement of the model medium (this 
system can be considered as a flow system at a first 
approximation) and with taking 4 ml samples with their 
subsequent return and addition of the original medium 
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to maintain required volume if necessary (closed 
system). 
Statistical processing of the results was 
carried out using SPSS Statistics v17 Multilingual-
EQUiNOX (SPSS Inc.) software. 
 
 
Results 
 
We studied the influence of the base-forming 
substances in the working composition on the delivery 
of flavonoids into 0.1 n. Sodium hydroxide solution in 
a flow system during phonophoresis. It was found 
that, during the first ten minutes of the experiment (the 
approximate duration of the phonophoresis 
procedure), more than 5% of flavonoids diffused into 
the model medium from the working composition W2, 
about 4% from the composition W4 and less than 3% 
from the composition W5. According to the results of 
the organoleptic control, the drying-up testing, the pH 
value determination and the thermal stability, the 
compositions with the best properties were W2 and 
W4. Analysis of the rheological characteristics of the 
working compositions demonstrated that the working 
composition W2 is optimal for the use in ultrasound 
therapy, it can be used with the prolonged application 
to the skin, it is sufficiently stable over time, which 
facilitates the preservation of the good quality of the 
drug during storage. Therefore, we used a basis with 
Carbopol to prepare the working compositions W1, 
W2, and W3 for further research. 
The study of the kinetics of the flavonoids 
delivery from working compositions with different 
phytocomplex concentrations into 0.1 n. Sodium 
hydroxide solution in a closed system during 
phonophoresis showed that within four hours of the 
experiment approximately 43% of flavonoids diffused 
into the model medium from the working composition 
W1, about 26% – from composition W2, and about 
20% – from composition W3 (Figure 1).  
 
Figure 1: Kinetics of flavonoids delivery from the phytocomplex 
working compositions into 0.1 n. sodium hydroxide solution through 
Carbosil-P membranes when the equilibrium was reached in a 
closed system at 23°C during phonophoresis (C is the 
concentration of flavonoids in the model medium) 
The equilibrium was reached in 3.5-4 hours. 
“Time lag” was 2.5-3 minutes. The flavonoids delivery 
rate from working compositions with different 
phytocomplex concentrations was directly proportional 
to the initial active substances concentrations in the 
compositions at the beginning of the experiment and 
sharply decreased by the time the equilibrium was 
reached. 
It is known that the time lag has a significant 
effect on the diffusion process of substances into the 
model medium through a membrane. The diffusion 
coefficient (D) is calculated using the formula: 
D = l
2
 /6Θ, 
where l is the film thickness, Θ is the time lag. 
For comparison, we determined the time lag 
for the flavonoid's delivery from the composition W2 
into 0.1 n. Sodium hydroxide solution without 
exposure to ultrasound – it was 3.5 minutes. 
Increasing the temperature of the applied working 
composition to 42°C reduced the time lag to three 
minutes. For rational use of the phytocomplex and 
increased therapeutic efficacy of the method, it is 
advisable to apply warm (40-42°C) working 
composition to the skin surface in the affected joint 
area, leave it for three minutes and then expose to 
ultrasound. 
Periodic replacement of the model medium 
(flow system) allowed us to obtain a broader picture of 
the kinetics of the flavonoids delivery from working 
compositions with phytocomplex during 
phonophoresis — the maximum rate of flavonoids 
delivery from the composition W1 into 0.1 n. Sodium 
hydroxide solution was achieved after 30 minutes of 
the experiment, from compositions W2 and W3 – after 
20 minutes (Table 1). 
Table 1: Kinetics of flavonoids delivery from phytocomplex 
working compositions into 0.1 n. sodium hydroxide solution 
through Carbosil-P membranes inflow system at 42°C during 
phonophoresis 
Time 
Rate (V) and proportion (Р) of flavonoids delivery 
5% phytocomplex 
working composition 
(W1) 
10% phytocomplex 
working composition 
(W2) 
15% phytocomplex 
working composition 
(W3) 
V∙10
5
, g/ml∙h Р, % V∙10
5
, g/ml∙h Р, % V∙10
5
, g/ml∙h Р, % 
10 min 60.9 ± 0.2 5.6 114.7 ± 0.3 5.3 147.9 ± 0.4 4.7 
20 min 81.8 ± 0.3 13.2 141.1 ± 0.6 11.8 178.2 ± 0.5 10.5 
30 min 94.0 ± 0.3 21.9 136.1 ± 0.4 18.1 154.8 ± 0.6 15.4 
40 min 71.1 ± 0.2 28.5 130.9 ± 0.5 24.2 145.1 ± 0.5 20.1 
1 h 55.3 ± 0.2 38.7 106.2 ± 0.5 34.0 125.6 ± 0.5 28.1 
2 h 39.9 ± 0.2 60.9 78.8 ± 0.3 55.9 113.9 ± 0.4 50.0 
4 h 18.1 ± 0.1 81.0 38.0 ± 0.2 77.0 62.3 ± 0.4 74.0 
6 h 9.2 ± 0.1 91.3 19.2 ± 0.1 87.7 28.7 ± 0.2 85.0 
8 h 4.4 ± 0.1 96.2 9.3 ± 0.1 92.9 14.1 ± 0.1 90.5 
 
To increase the delivery rate of flavonoids, 
during the first ten minutes of the experiment, dimethyl 
sulfoxide (DMSO) was added into the working 
composition W2 with 10% and 15% DMSO 
concentrations were chosen also due to anti-
inflammatory, analgesic and antimicrobial effects. A 
significant effect of DMSO on the delivery of 
flavonoids during the first several minutes of the 
experiment was recorded. For example, after ten 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2082                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
minutes of the experiment, the rate of flavonoids 
delivery from the working composition W2 with 10% of 
DMSO increased by more than 1.5 times, and 15% 
DMSO concentration resulted in an almost twofold 
increase (Table 2). The time lag was 2-2.5 minutes. 
Table 2: Kinetics of delivery of flavonoids from working 
compositions containing DMSO, in 0.1 n. sodium hydroxide 
solution through membranes Carbosil-P inflow system at 42°C 
with phonophoresis 
Time 
Rate (V) and proportion (Р) of flavonoids delivery 
W2 + 10% of DMSO W2 + 15% of DMSO W2 + 10% of DMSO* 
V∙10
5
, g/ml∙h Р, % V∙10
5
, g/ml∙h Р, % V∙10
5
, g/ml∙h Р, % 
10 min 173.3 ± 0.5 8.0 273.0 ± 0.7 10.5 216.0 ± 0.5 10.0 
20 min 222.0 ± 0.6 18.3 264.8 ± 0.6 24.9 110.2 ± 0.4 15.1 
30 min 190.1 ± 0.5 27.1 233.3 ± 0.5 35.7 67.0 ± 0.3 18.2 
40 min 159.8 ± 0.4 34.5 183.6 ± 0.5 44.2 45.4 ± 0.2 20.3 
1 h 145.8 ± 0.4 48.0 126.4 ± 0.4 55.9 40.0 ± 0.2 24.0 
2 h 78.5 ± 0.3 69.8 66.6 ± 0.2 74.4 36.4 ± 0.2 34.1 
4 h 31.1 ± 0.2 87.1 28.4 ± 0.2 90.2 26.8 ± 0.2 49.0 
6 h 12.8 ± 0.1 94.2 9.5 ± 0.1 95.5 16.9 ± 0.1 58.4 
8 h 4.1 ± 0.1 96.5 - - 5.2 ± 0.1 61.3 
*The working composition was exposed to ultrasound (beginning of the experiment) three 
minutes after it was applied warm (42°C) on the Carbosyl-P membrane. Ultrasound 
exposure time was ten minutes. 
 
The results for the flavonoids delivery from 
working compositions based on W2 with 10% and 
15% of DMSO into a 0.9% sodium chloride solution 
also indicated an increase in the phytocomplex active 
ingredients delivery rate. 
An analysis of the rheological properties of 
working compositions with DMSO showed that 
composition W2 with 10% of DMSO had optimal 
plastic viscosity and yield value for ultrasound 
therapy. 
 
Figure 2: Control of the transdзermal flavonoids delivery 
process from the phytocomplex working compositions during 
phonophoresis (red colour indicates the time of the phonophoresis 
procedure) 
 
In order to increase pharmacokinetics 
measuring parameters of the process and make the 
use of the phytocomplex more rational, the following 
techniques were proposed: application of a thin layer 
of warm (40-42°C) working composition locally to the 
skin surface in the affected joint area followed by two 
or three minutes of wait time before the ultrasound 
exposure using contact labile method with an intensity 
of 0.6-0.8 W/cm
2
 in a continuous mode lasting ten 
minutes, with working composition subsequently left 
on the skin for up to 6-8 hours (as an ointment) (Table 
2, Figure 2). It should be noted that with the use of 
this technology, the flavonoids delivery rate from the 
working composition W2 with 10% of DMSO 
immediately after exposure to ultrasound is similar to 
that of composition W2 with 15% of DMSO, and the 
proportion of active substances delivery at the end of 
the experiment is almost eight times higher compared 
to traditional phonophoresis procedure. 
 
 
Discussion 
 
We presented pharmacokinetics measuring 
parameters of the transdermal flavonoids delivery 
process from the phytocomplex working compositions 
during phonophoresis in vitro model experiments: the 
maximum concentration of flavonoids in model media, 
the time of achievement of maximum concentration in 
model media, the rate and degree of release of 
flavonoids from the dosage form. The optimal dosage 
of the phytocomplex in working compositions was 
established – 10%. The main parameters of the 
process were determined; the dependence of the 
flavonoids delivery rate on their initial concentration in 
the working composition was established. The effect 
of dimethyl sulfoxide and the base-forming 
substances in the working composition on the delivery 
of phytocomplex flavonoids during phonophoresis was 
studied. An almost 1.5-2 times increase in the delivery 
rate of the active substances from working 
compositions containing dimethyl sulfoxide into the 
model medium during the first ten minutes of the 
experiment (approximate duration of the 
phonophoresis procedure) were recorded. 
Technological methods for the increase of the 
efficiency of the phonophoresis method and rational 
use of the phytocomplex were proposed. The 
obtained results give grounds for further 
pharmacological studies of the nature and mechanism 
of the effect of phytocomplex flavonoids during 
phonophoresis in the rehabilitation of patients with 
osteoarthrosis. 
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